Association of nesfatin-1 level with body composition, dietary intake and resting metabolic rate in obese and morbid obese subjects

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 9, Issue 4, 2015, Pages 292-298

  Mirzaei, Khadijeh ^a   Hossein Nezhad, Arash ^b,c   Keshavarz, Seyed Ali ^a   Koohdani, Fariba ^a   Eshraghian, Mohammad Reza ^b   Saboor Yaraghi, Ali Akbar ^a   Hosseini, Saeed ^a   Chamari, Maryam ^a   Zareei, Mahnaz ^a   Djalali, Mahmoud ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dietary intake; Nesfatin 1; PPAR , Obesity; Resting metabolic rate

Indexed keywords

BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; DNA BINDING PROTEIN; NERVE PROTEIN; NUCLEOBINDIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; BASAL METABOLIC RATE; BLOOD; BODY COMPOSITION; BODY MASS; CALORIC INTAKE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; FOLLOW UP; HUMAN; INDIRECT CALORIMETRY; INSULIN RESISTANCE; MALE; MORBID OBESITY; OBESITY; PATHOPHYSIOLOGY; PROGNOSIS; RISK FACTOR;

ADULT; BASAL METABOLISM; BIOMARKERS; BODY COMPOSITION; BODY MASS INDEX; CALCIUM-BINDING PROTEINS; CALORIMETRY, INDIRECT; CROSS-SECTIONAL STUDIES; DNA-BINDING PROTEINS; ENERGY INTAKE; FASTING; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN RESISTANCE; MALE; NERVE TISSUE PROTEINS; OBESITY; OBESITY, MORBID; PPAR GAMMA; PROGNOSIS; RISK FACTORS;

EID: 84900876196     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2014.04.010     Document Type: Article

References (28)

1. S.J. Guyenet, and M.W. Schwartz Clinical review: regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity J Clin Endocrinol Metab 97 2012 745 755
2. M. Ramanjaneya, J. Chen, J.E. Brown, G. Tripathi, M. Hallschmid, S. Patel, and et al. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity Endocrinology 151 2010 3169 3180
3. I.S. Oh, H. Shimizu, T. Satoh, S. Okada, S. Adachi, K. Inoue, and et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus Nature 443 2006 709 712
4. M. Yamada, K. Horiguchi, R. Umezawa, K. Hashimoto, T. Satoh, A. Ozawa, and et al. Troglitazone, a ligand of peroxisome proliferator-activated receptor-{gamma}, stabilizes NUCB2 (Nesfatin) mRNA by activating the ERK1/2 pathway: isolation and characterization of the human NUCB2 gene Endocrinology 151 2010 2494 2503
5. M. Goebel-Stengel, and L. Wang Central and peripheral expression and distribution of NUBC2/nesfatin-1 Curr Pharm Des 25 2013 25
6. M. Ramanjaneya, M. Addison, and H.S. Randeva Possible role of NUBC2/nesfatin-1 in adipogenesis Curr Pharm Des 25 2013 25
7. H. Waki, T. Yamauchi, and T. Kadowaki Regulation of differentiation and hypertrophy of adipocytes and adipokine network by PPARgamma Nihon Rinsho 68 2010 210 216
8. E.D. Rosen, P. Sarraf, A.E. Troy, G. Bradwin, K. Moore, D.S. Milstone, and et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro Mol Cell 4 1999 611 617
9. A. Okuno, H. Tamemoto, K. Tobe, K. Ueki, Y. Mori, K. Iwamoto, and et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats J Clin Invest 101 1998 1354 1361
10. M.M. Sale, and S.S. Rich Genetic contributions to type 2 diabetes: recent insights Expert Rev Mol Diagn 7 2007 207 217
11. K. Mirzaei, A. Hossein-Nezhad, M. Chamari, and S. Shahbazi Evidence of a role of ANGPTL6 in resting metabolic rate and its potential application in treatment of obesity Minerva Endocrinol 36 2011 13 21
12. Q.C. Li, H.Y. Wang, X. Chen, H.Z. Guan, and Z.Y. Jiang Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans Regul Pept 159 2010 72 77
13. 2+ influx through N-type channels Biochem Biophys Res Commun 390 2009 958 962
14. R. Gonzalez, B.K. Reingold, X. Gao, M.P. Gaidhu, R.G. Tsushima, and S. Unniappan Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet beta- and MIN6 cells J Endocrinol 208 2011 R9 R16
15. R.I. Cohen, N. Ginsberg, D. Tsang, L.C. Wann, X. Ye, and S.F. Liu Association of nesfatin-1 and fat mass in cystic fibrosis Respiration 8 2013 8
16. T. Tsuchiya, H. Shimizu, M. Yamada, A. Osaki, I.S. Oh, Y. Ariyama, and et al. Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males Clin Endocrinol 73 2010 484 490
17. B.K. Tan, M. Hallschmid, W. Kern, H. Lehnert, and H.S. Randeva Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment J Clin Endocrinol Metab 96 2011 1782 2010
18. J.F. Saldanha, J.J. Carrero, J.C. Lobo, M.B. Stockler-Pinto, V.O. Leal, A. Calixto, and et al. The newly identified anorexigenic adipokine nesfatin-1 in hemodialysis patients: are there associations with food intake, body composition and inflammation Regul Pept 173 2012 82 85
19. W. Pan, H. Hsuchou, and A.J. Kastin Nesfatin-1 crosses the blood-brain barrier without saturation Peptides 28 2007 2223 2228
20. T.O. Price, W.K. Samson, M.L. Niehoff, and W.A. Banks Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1 Peptides 28 2007 2372 2381
21. M. Qatanani, and M.A. Lazar Mechanisms of obesity-associated insulin resistance: many choices on the menu Genes Dev 21 2007 1443 1455
22. Y. Gui, J.V. Silha, S. Mishra, and L.J. Murphy Changes in adipokine expression during food deprivation in the mouse and the relationship to fasting-induced insulin resistance Can J Physiol Pharmacol 81 2003 979 985
23. A. Stengel, M. Goebel, and Y. Tache Nesfatin-1: a novel inhibitory regulator of food intake and body weight Obes Rev 12 2011 261 271
24. W.M. Miller, T.J. Spring, K.C. Zalesin, K.R. Kaeding, K.E. Nori Janosz, P.A. McCullough, and et al. Lower than predicted resting metabolic rate is associated with severely impaired cardiorespiratory fitness in obese individuals Obesity 20 2012 505 511
25. R. Gonzalez, R.L. Perry, X. Gao, M.P. Gaidhu, R.G. Tsushima, R.B. Ceddia, and et al. Nutrient responsive nesfatin-1 regulates energy balance and induces glucose-stimulated insulin secretion in rats Endocrinology 152 2011 3628 3637
26. J.K. Elmquist, R. Coppari, N. Balthasar, M. Ichinose, and B.B. Lowell Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis J Comp Neurol 493 2005 63 71
27. K. Konczol, O. Pinter, S. Ferenczi, M. Ichinose, and B.B. Lowell Nesfatin-1 exerts long-term effect on food intake and body temperature Int J Obes 36 2012 1514 1521
28. H. Shimizu, I.S. Oh, K. Hashimoto, M. Nakata, S. Yamamoto, N. Yoshida, and et al. Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism Endocrinology 150 2009 662 671